Join to view full profile
4301 W Markham St# 506Little Rock, AR 72205
Phone+1 501-686-8000
Fax+1 501-526-5148
Dr. Baljevic is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2010 - 2013
Weill Cornell Medical College in QatarClass of 2010
Certifications & Licensure
AR State Medical License 2026 - 2026
TN State Medical License 2021 - 2026
NE State Medical License 2016 - 2022
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- 2 citationsOutpatient Administration of Bispecific Antibody Therapy for Hematologic Malignancies: A Practical Guide.Kian J Rahbari, Raul Del Toro Mijares, Kathryn Kennedy, Leslie Mader, Salyka Sengsayadeth
JCO Oncology Practice. 2026-09-01 - Long-term safety and efficacy of BCMA-directed CAR T-cell therapies in multiple myeloma: comparative insights from Cilta-cel, Ide-cel, Anito-cel, and FCARH143.Bryanna Reinhardt, Phyu Thin Naing, Muhamed Baljevic
Translational Cancer Research. 2026-08-31 - Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma.Callee Brooks, Leslie Mader, Kathryn Kennedy, Phyu Thin Naing, Salyka Sengsayadeth
Experimental Hematology & Oncology. 2026-08-12
Abstracts/Posters
- Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Newly Diagnosed Multiple MyelomaMuhamed Baljevic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma _ Single Institution ExperienceMuhamed Baljevic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Guide Published for Outpatient Cancer Treatment with Bispecific AntibodiesJanuary 12th, 2026
New Faculty Spotlight: Muhamed Baljevic, M.DNovember 14th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: